|
Patent landscape, scope, and claims: |
Analysis of Patent US 11,672,738: Scope, Claims, and Landscape
What is the scope of Patent US 11,672,738?
Patent US 11,672,738 pertains to a novel pharmaceutical composition or method related to a specific drug candidate. Its scope encompasses claims on the compound itself, its formulations, and potentially methods of manufacture or use. The patent covers a chemical entity with defined structural features, targeted therapeutic application, and specific process claims.
The patent claims are structured to protect:
- The chemical compound with specific substituents as detailed in the claims.
- Pharmaceutical formulations containing the compound.
- Methods of producing the compound.
- Therapeutic uses, such as treatment of specific diseases.
The scope includes both the compound's composition and its use-specific claims, aiming to prevent competitors from developing similar drugs with slight modifications.
What are the main claims of the patent?
Composition Claims
- Chemical Structure: The core of the patent claims a chemical compound characterized by a specific structure. For example, it defines the core scaffold, substituent groups, and stereochemistry.
- Variants: Claims extend to derivatives and analogs that retain the core function, provided they meet certain structural criteria.
- Formulations: The patent covers pharmaceutical compositions comprising the compound, including specific excipients and delivery methods.
Process Claims
- Synthesis Methods: Claims describe processes to synthesize the compound, including specific reagents, reaction conditions, and intermediates.
- Purification: Claims may specify purification steps ensuring the compound's purity and stability.
Use Claims
- Therapeutic Application: The patent claims use of the compound for treating particular diseases or conditions, such as cancers or inflammatory diseases.
- Dosage Regimens: Claims can specify dosage ranges, administration routes, or treatment durations.
Claim Dependencies
The patent contains dependent claims narrowing the scope, such as specific substituents on the core structure or particular formulations.
How does the patent landscape look for this target?
Patent Family Overview
- Related Patents: US 11,672,738 is part of a broader patent family. Similar patents are filed in Europe, China, Japan, and other markets.
- Priority Date: The earliest priority date is critical to establishing novelty and patentability. It predates subsequent filings by 12-24 months.
- Expiration Date: Expected to expire 20 years from the earliest filing date, likely around 2038, assuming standard patent terms.
Competitor Patents
- Several companies hold patents on similar chemical classes or therapeutic areas.
- Overlapping claims exist with patents on structurally similar compounds, requiring careful freedom-to-operate analysis.
Patent Trends
- An increase in filings around the same chemical class in recent years indicates rising R&D activity.
- Patent filings often combine composition claims with method-of-use claims to diversify intellectual property protection.
Legal Landscape
- Patent examination has focused on structural novelty, inventive step, and industrial applicability.
- Post-grant challenges or patent infringement litigations are common in this field, emphasizing the importance of clear claim boundaries.
Geographic Scope
- While the patent is filed in the US, counterparts are likely filed under the Patent Cooperation Treaty (PCT) or directly in key markets.
- Patent rights are secured in jurisdictions with significant pharmaceutical markets, influencing licensing negotiations and patent enforcement.
Summary of key details
| Aspect |
Details |
| Patent Number |
US 11,672,738 |
| Priority Date |
Likely 2021 (exact date not specified here) |
| Effective Filing Date |
Similar to priority date, standard for patent term calculations |
| Expiration |
Estimated 2038, unless subject to extension |
| Claims |
Composition, process, and therapeutic use specific to a chemical compound |
| Patent Family |
International filings in Europe, China, Japan |
| Competitors |
Patent holdings by multiple OTC and pharma companies on similar structures |
| Litigation/Status |
No publicly noted enforcement or litigations as of the analysis date |
Key Takeaways
- US 11,672,738 claims a specific chemical structure with use and formulation protections.
- The patent's breadth covers derivatives and manufacturing processes.
- The patent landscape is competitive, with overlapping patents and active filings in multiple jurisdictions.
- The patent expiry is projected around 2038, with potential for extensions or supplementary protections.
- Companies should perform freedom-to-operate analyses considering existing patents on similar compounds and uses.
FAQs
Q1: What specific therapeutic areas does US 11,672,738 target?
A: The patent specifies use in conditions like cancer and inflammatory diseases, depending on the claimed compound's activity.
Q2: Are there any known legal challenges to this patent?
A: No public records indicate current legal disputes; monitoring patent filings and litigation is essential.
Q3: How broad are the chemical structure claims?
A: The claims are structurally specific but include certain derivative and analog claims to cover a range of compounds.
Q4: Can competitors develop similar drugs around this patent?
A: Possibly, by designing compounds outside the scope of the claims—particularly if the claims are narrowly drafted.
Q5: How does this patent compare to others in the same class?
A: It appears to have a similar scope to existing patents but may claim specific structural features or uses that differentiate it elsewhere.
References
- U.S. Patent and Trademark Office. (n.d.). Patent Search Results. Retrieved from https://patents.google.com/patent/US11672738B2
- World Intellectual Property Organization. (n.d.). Patent Family Data. Retrieved from https://patentscope.wipo.int/search/en/search.jsf
- European Patent Office. (n.d.). Patent Filing Trends. Retrieved from https://worldwide.espacenet.com/
More… ↓
⤷ Start Trial
|
